Sectoral Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-451,247
| Closed | -$10.7M | – | 79 |
|
|
2019
Q3 | $10.7M | Sell |
451,247
-214,466
| -32% | -$5.07M | 1.84% | 22 |
|
|
2019
Q2 | $20M | Sell |
665,713
-20,800
| -3% | -$625K | 2.39% | 11 |
|
|
2019
Q1 | $15.4M | Sell |
686,513
-113,099
| -14% | -$2.53M | 1.85% | 16 |
|
|
2018
Q4 | $14.6M | Buy |
799,612
+450,900
| +129% | +$8.21M | 1.98% | 15 |
|
|
2018
Q3 | $6.31M | Buy |
+348,712
| New | +$6.31M | 0.67% | 47 |
|
|
2017
Q4 | – | Sell |
-278,082
| Closed | -$4.06M | – | 73 |
|
|
2017
Q3 | $4.06M | Buy |
278,082
+99,332
| +56% | +$1.45M | 0.52% | 44 |
|
|
2017
Q2 | $3.35M | Sell |
178,750
-46,590
| -21% | -$873K | 0.37% | 44 |
|
|
2017
Q1 | $4.8M | Sell |
225,340
-27,600
| -11% | -$588K | 0.56% | 39 |
|
|
2016
Q4 | $3.84M | Buy |
+252,940
| New | +$3.84M | 0.43% | 40 |
|